BEIJING, Oct. 26, 2015 /PRNewswire/ -- Dehaier Medical Systems Ltd. (Nasdaq: DHRM) ("Dehaier" or the "Company"), which develops, markets and sells medical devices and wearable sleep respiratory products in China and international markets, today announced that it has been awarded a medical equipment procurement agreement from China's Health & Anti-Poverty Program Committee ("HAPP Committee"). According to the agreement, Dehaier will provide anesthesia equipment systems, mobile C-Arm X-Ray machines and medical molecular sieve oxygen generators to hospitals that are financed by the HAPP.
The HAPP is an aid program initiated by China Primary Healthcare Foundation and Chinese Red Cross Foundation in 2002. The program is aimed at aiding institutions of basic level medical services with medical equipment and aimed at improving medical infrastructure of essential, rural and poverty areas. By the end of 2013, the Program including "Essential Medical Infrastructure Construction Project", "Disease Prevention Project in Social Communities" and "Training Project of Healthcare Practitioners" was implemented in 32 provinces, autonomous regions, municipalities, 200 cities and 1000 counties across China, benefiting approximately 150 million people, with an economic impact of approximately RMB 3 billion.
"We are pleased to be chosen as qualified equipment and service provider of the HAPP. Since this year, we have furthered our business model transformation and we are continuing diversify our cooperation with key account customers. We primarily focus on state-level and other large-scale procurement projects to foster and develop business with emerging clients with significant purchasing power. Dehaier believes its commitment to exceeding customer expectations and developing long-term and reliable relationships with leading Chinese medical institutions have made Dehaier successful in winning large projects like this new one with HAPP," said Mr. Ping Chen, CEO of Dehaier. "The time and resources we have devoted to our key account team have paid off for Dehaier. As China keeps found allocation in construction of healthcare infrastructure, Dehaier will continue to leverage its experience and resources to grow with the industry."
About Dehaier Medical Systems Ltd.
Dehaier is an emerging leader in the development, marketing and sale of medical products, including medical devices and wearable sleep respiratory products. The company develops and assembles its self-branded medical devices and sleep respiratory products from third-party components. The company also distributes products designed and manufactured by other companies, including medical devices from IMD (Italy), HEYER (Germany) and Timesco (UK). Dehaier's technology is based on seven patents and eleven software copyrights. More information may be found at http://www.dehaier.com.cn.
This news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, fulfillment of bids and contracts, changes in technology, economic conditions, the impact of competition and pricing, government regulation, and other risks contained in reports filed by the company with the Securities and Exchange Commission. All such forward-looking statements, whether written or oral, and whether made by or on behalf of the company, are expressly qualified by the cautionary statements and any other cautionary statements which may accompany the forward-looking statements. In addition, the company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.
For more information, please contact:
Dehaier Medical Systems Limited
+86 10-5166-0080 ext.211
SOURCE Dehaier Medical Systems Ltd.